EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Versus Oxidized NAD + Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes

Kasper T Vinten iD, Bauke V Schomakers iD, Simone Denis, Michel van Weeghel iD, Aldo Jongejan iD, Rob Ofman iD, Sander R Piersma iD, Connie R Jimenez iD, Georges E Janssens iD, Rubén Zapata-Pérez iD, Riekelt H Houtkooper iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202501925r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Kasper T Vinten und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Hepatocytes, NAD, Transcriptome, Metabolome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC | HORIZON EUROPE Framework Programme (Horizon Europe), Ministerio de Ciencia, Innovación y Universidades (MCIU), HORIZON EUROPE Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide adenine dinucleotide (NAD + ) is a vital molecule, serving as a redox cofactor and the limiting substrate for numerous enzymes. NAD + decline is a key feature of aging, while supplementation with NAD + precursors can efficiently counteract aging traits and prevent age‐associated conditions in preclinical models. However, clinical translation remains challenging, likely due to the limited NAD + boosting capacity of classical precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). This has brought attention to their reduced forms, reduced NMN (NMNH) and reduced NR (NRH), which are more potent NAD + boosters but remain poorly characterized. Here, we performed a comprehensive comparative analysis using RNA sequencing, proteomics, and metabolomics on cultured murine hepatocytes treated with NMN, NMNH, NR, or NRH. Global metabolic profiling revealed that NRH and NMNH induced substantially broader metabolic alterations than NR and NMN, with NRH uniquely suppressing metabolites involved in energy metabolism. The pronounced metabolic effects were reflected at a transcriptional level, with reduced precursors triggering a significantly higher number of differentially expressed genes than oxidized ones. Shared differentially expressed genes between NMNH and NRH revealed upregulation of stress‐related glutathione‐ S ‐transferases ( Gsts ) which furthermore were reflected in our proteomic profiling. However, the upregulation of Gsts did not cause a depletion of glutathione or oxiglutathione, suggesting a pseudo‐stress response to reduced NAD + precursors. Together, our data demonstrate that reduced NAD + precursors are unique and distinct from the market‐available NAD + precursors NR and NMN, not only as more potent NAD + boosters, but also as compounds influencing a broader range of cellular processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesNADTranscriptomeMetabolomeProteomeAnimalsProteomicsMiceOxidation-ReductionNiacinamideNicotinamide MononucleotidePyridinium CompoundsCells, CulturedMetabolomicsMice, Inbred C57BL

Stichwörter der Autor:innen

NAD+NAD+ precursorscomparative analysishepatocytes

Substanzen

NADNiacinamideNicotinamide Mononucleotidenicotinamide-beta-ribosidePyridinium CompoundsProteome

Autor:innen und Institutionen

  • Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Gastroenterology, Endocrinology, and Metabolism Institute, Amsterdam UMC, Amsterdam, the Netherlands.
  • Core Facility Metabolomics, Amsterdam UMC, Amsterdam, the Netherlands.
  • Amsterdam Cardiovascular Sciences Institute, Amsterdam UMC, Amsterdam, the Netherlands.
  • Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Public Health Methodology, Amsterdam UMC, Amsterdam, the Netherlands.

ORCID-Profile: Kasper T Vinten, Bauke V Schomakers, Michel van Weeghel, Aldo Jongejan, Rob Ofman, Sander R Piersma, Connie R Jimenez, Georges E Janssens, Rubén Zapata-Pérez, Riekelt H Houtkooper

Förderung

  • EC | HORIZON EUROPE Framework Programme (Horizon Europe)
  • Ministerio de Ciencia, Innovación y Universidades (MCIU)
  • HORIZON EUROPE Framework Programme

Zitieren

APA

Vinten, K. T., Schomakers, B. V., Denis, S., van Weeghel, M., Jongejan, A., Ofman, R., Piersma, S. R., Jimenez, C. R., Janssens, G. E., Zapata-Pérez, R., & Houtkooper, R. H. (2026). Reduced Versus Oxidized NAD + Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes. The FASEB Journal. https://doi.org/10.1096/fj.202501925r

Vancouver

Vinten KT, Schomakers BV, Denis S, van Weeghel M, Jongejan A, Ofman R, et al. Reduced Versus Oxidized NAD + Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes. The FASEB Journal. 2026. doi:10.1096/fj.202501925r

BibTeX
@article{Vinten2026,
  author = {Vinten, Kasper T and Schomakers, Bauke V and Denis, Simone and van Weeghel, Michel and Jongejan, Aldo and Ofman, Rob and Piersma, Sander R and Jimenez, Connie R and Janssens, Georges E and Zapata-Pérez, Rubén and Houtkooper, Riekelt H},
  title = {Reduced Versus Oxidized NAD + Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202501925r}
}
Kostenlos starten →